Last updated on February 2019

Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma

Brief description of study

The primary objective of this study is to obtain de-identified, clinically-characterized whole blood specimens for use in developing and evaluating the performance of new biomarker assays for detection of hepatocellular carcinoma (HCC).

Detailed Study Description

Subjects with untreated Hepatocellular Carcinoma (HCC) and subjects undergoing HCC surveillance will be enrolled and have blood samples collected. Subjects undergoing HCC surveillance will be followed for 6 months and another blood sample collected at the 6 month time point.

Clinical Study Identifier: NCT03628651

Contact Investigators or Research Sites near you

Start Over

Nadja Rieckehr

Helios Klinikum Berlin-Buch
Berlin, Germany
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.